Joint Communiqué: BioNTech Evaluates mRNA Vaccine Manufacturing Solutions in Rwanda and Senegal to Improve Long-Term Vaccine Supply

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. TRMD
9. ACN
10. AZN

Go back to Joint Communiqué: BioNTech Evaluates mRNA Vaccine Manufacturing Solutions in Rwanda and Senegal to Improve Long-Term Vaccine Supply
(NASDAQ: BNTX) Delayed: 96.06 -2.6 (2.64%)
Previous Close $98.66    52 Week High $ 
Open $98.81    52 Week Low $ 
Day High $99.25    P/E N/A 
Day Low $95.71    EPS $ 
Volume 1,195,347